These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 16121805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT, Nagalla SR.
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H.
    J Diabetes Complications; 2005 Mar; 19(4):223-32. PubMed ID: 15993357
    [Abstract] [Full Text] [Related]

  • 7. Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy.
    Shore N, Khurshid R, Saleem M.
    J Ayub Med Coll Abbottabad; 2010 Mar; 22(4):53-5. PubMed ID: 22455261
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic strategy to monitor diabetic nephropathy.
    Rowe DJ, Twyman S.
    Kidney Int Suppl; 1994 Nov; 47():S109-10. PubMed ID: 7869658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
    Lapolla A, Molin L, Sechi A, Cosma C, Ragazzi E, Seraglia R, Traldi P.
    J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
    [Abstract] [Full Text] [Related]

  • 15. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects.
    Canter MP, Graham CA, Heit MH, Blackwell LS, Wilkey DW, Klein JB, Merchant ML.
    Am J Obstet Gynecol; 2008 May; 198(5):553.e1-6. PubMed ID: 18455532
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of Albusure test in screening for early stage of diabetic nephropathy.
    Zhang J, Lnoue K, Nakashima N, Hiramatsu S, Ohashi M, Umeda F, Nawata H.
    Chin Med J (Engl); 1994 Sep; 107(9):699-702. PubMed ID: 7805464
    [Abstract] [Full Text] [Related]

  • 18. [Revised criteria for the early diagnosis of diabetic nephropathy].
    Inomat S, Haneda M, Moriya T, Katayama S, Iwamoto Y, Sakai H, Tomino Y, Matsuo S, Asano Y, Makino H, Diabetic Nephropha Committee.
    Nihon Jinzo Gakkai Shi; 2005 Sep; 47(7):767-9. PubMed ID: 16296406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.